Skip to main content

Table 6 Incidence of breakthrough bleeding during treatment with EE/CMA or EE/DRSP

From: A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

 

EE /CMA

n (%)

EE /DRSP

n (%)

Month 1

8 (9.0)

15 (16.9)

Month 3

8 (9.2)

11 (12.4)

Month 6

0 (0.0)

2 (2.3)

  1. Note: No significant difference between treatment groups
Back to article page

Contraception and Reproductive Medicine

ISSN: 2055-7426

Contact us